Trademark: 86064572
Word
AILIQIN
Status
Dead
Status Code
710
Status Date
Friday, January 15, 2021
Serial Number
86064572
Registration Number
4546835
Registration Date
Tuesday, June 10, 2014
Mark Type
3000
Filing Date
Friday, September 13, 2013
Published for Opposition
Tuesday, March 25, 2014
Cancellation Date
Friday, January 15, 2021

Trademark Owner History

Classifications
5 Fungicides; medicinal infusions for treating skin disease; medicated lotions for skin, hair, sunburn, face, body; vaginal washes; antibacterial pharmaceuticals; pharmaceutical agents for epidermis; pharmaceutical agents for treating physically caused lesions; anti-itch ointment; adjuvants for medical purposes; germicides; antibacterial spray; all purpose disinfectants; antibacterial substances for medical purposes
Color is not claimed as a feature of the mark.
The mark consists of Chinese characters above "AILIQING", all contained within an oval.
The non-Latin characters in the mark transliterate to "AI", "LI" and "QING" and are being used for their phonetic values to approximate the sound of the English characters in the mark and not for their individual meanings, and they also do not convey a meaning when read together.

Trademark Events
Jan 15, 2021
Cancelled Sec. 8 (6-Yr)
Jun 10, 2019
Courtesy Reminder - Sec. 8 (6-Yr) E-Mailed
Jun 10, 2014
Registered-Principal Register
Mar 25, 2014
Official Gazette Publication Confirmation E-Mailed
Mar 25, 2014
Published For Opposition
Mar 5, 2014
Notification Of Notice Of Publication E-Mailed
Feb 18, 2014
Law Office Publication Review Completed
Feb 15, 2014
Assigned To Lie
Jan 28, 2014
Approved For Pub - Principal Register
Jan 28, 2014
Examiner's Amendment Entered
Jan 28, 2014
Notification Of Examiners Amendment E-Mailed
Jan 28, 2014
Examiners Amendment E-Mailed
Jan 28, 2014
Examiners Amendment -Written
Dec 23, 2013
Assigned To Examiner
Sep 24, 2013
Notice Of Design Search Code E-Mailed
Sep 23, 2013
New Application Office Supplied Data Entered In Tram
Sep 17, 2013
New Application Entered In Tram

Trademark Alertz updated from USPTO on 2030-01-24